These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Levamisole treatment in steroid sensitive nephrotic syndrome. Alshaya HO; Kari JA Saudi Med J; 2002 Sep; 23(9):1101-4. PubMed ID: 12370722 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome. Abeyagunawardena AS; Karunadasa U; Jayaweera H; Thalgahagoda S; Tennakoon S; Abeyagunawardena S Pediatr Nephrol; 2017 Aug; 32(8):1363-1367. PubMed ID: 28299461 [TBL] [Abstract][Full Text] [Related]
8. Short- and long-term efficacy of levamisole in children with steroid-sensitive nephrotic syndrome. Elmas AT; Tabel Y; Elmas ON Int Urol Nephrol; 2013 Aug; 45(4):1047-55. PubMed ID: 22826143 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects of levamisole treatment in childhood nephrotic syndrome. Sümegi V; Haszon I; Iványi B; Bereczki C; Papp F; Túri S Pediatr Nephrol; 2004 Dec; 19(12):1354-60. PubMed ID: 15517419 [TBL] [Abstract][Full Text] [Related]
10. Effect of levamisole in steroid-dependent nephrotic syndrome. Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369 [TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. Gruppen MP; Bouts AH; Jansen-van der Weide MC; Merkus MP; Zurowska A; Maternik M; Massella L; Emma F; Niaudet P; Cornelissen EAM; Schurmans T; Raes A; van de Walle J; van Dyck M; Gulati A; Bagga A; Davin JC; Kidney Int; 2018 Feb; 93(2):510-518. PubMed ID: 29054532 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome. Hoseini R; Sabzian K; Otukesh H; Zafaranloo N; Panahi P; Rahimzadeh N; Nakhaie S; Akhavan Sepehi M Iran J Kidney Dis; 2018 Jan; 12(1):27-32. PubMed ID: 29421774 [TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Bagga A; Hari P; Moudgil A; Jordan SC Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and -resistant nephrotic syndrome. Sümegi V; Haszon I; Bereczki C; Papp F; Túri S Pediatr Nephrol; 2008 Jul; 23(7):1085-92. PubMed ID: 18324421 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Sinha A; Puraswani M; Kalaivani M; Goyal P; Hari P; Bagga A Kidney Int; 2019 Jan; 95(1):210-218. PubMed ID: 30497684 [TBL] [Abstract][Full Text] [Related]